TCR2 Therapeutics Inc. carries a market capitalization of 58.11M, placing it among publicly traded companies globally.
| Market Cap | 58.11M |
| Enterprise Value | N/A |
TCR2 Therapeutics Inc.'s stock has declined approximately -48.96552% over the past 52 weeks. The 50-day moving average sits at 1.69, while the 200-day moving average is 1.56.
| Beta (5Y) | N/A |
| 52-Week Price Change | -48.96552% |
| 50-Day Moving Average | 1.69 |
| 200-Day Moving Average | 1.56 |
| Average Volume (20 Days) | N/A |